Target intelligence / Profile preview

Circulating inflammatory mediators and activated immune cells

Molecular classification
Other, Cytokine family, Chemokine family, Cellular ensemble
01

Overview

Circulating inflammatory mediators and activated immune cells represent a complex systemic physiological state rather than a single molecular target. This category encompasses a diverse array of signaling molecules, such as cytokines (e.g., TNF-alpha, IL-6), chemokines, and lipid mediators, alongside various activated leukocyte populations including T-lymphocytes, monocytes, and neutrophils (Medzhitov, 2008). In pathological states like sepsis, autoimmune disorders, and chronic cardiovascular disease, these components interact in a complex network to drive systemic inflammation and tissue damage (Dinarello, 2000). While therapeutic interventions often aim to modulate this milieu, they typically do so by targeting specific individual components, such as using monoclonal antibodies against specific cytokines, or through broad-spectrum immunosuppression (Hotchkiss et al., 2013). Consequently, this term serves as a descriptive label for the inflammatory environment rather than a discrete, druggable receptor or enzyme. Monitoring these mediators and cell states is crucial for diagnosing inflammatory severity and assessing the efficacy of immunomodulatory treatments in clinical practice (Tanaka et al., 2014). Drugs like Infliximab and Tocilizumab specifically target nodes within this network to alleviate chronic inflammation (Feldmann & Maini, 2001). Overall, understanding the interplay between these mediators and cells is vital for developing precision medicine approaches in immunology.

Other names
Systemic inflammatory milieuCirculating cytokines and activated leukocytesSystemic inflammatory response syndrome (SIRS) componentsInflammatory biomarkers and immune cell activation state
02

Mechanism of action

The mechanism of action involves the neutralization of specific pro-inflammatory cytokines, blockade of their respective receptors, or the broad suppression of immune cell gene expression and proliferation to reduce the systemic inflammatory burden (Feldmann & Maini, 2001; Tanaka et al., 2014).

03

Biological functions

Immune responseInflammationSignal transductionCellular activationChemotaxisAcute phase response
04

Disease associations

SepsisRheumatoid arthritisCytokine release syndromeSystemic lupus erythematosusCardiovascular diseaseInflammatory bowel disease
05

Safety considerations

Increased risk of serious infectionsReactivation of latent tuberculosisNeutropeniaHepatotoxicityHypersensitivity reactionsImpaired wound healing
06

Interacting drugs

Prednisone

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)ProcalcitoninErythrocyte sedimentation rate (ESR)CD64 expression on neutrophils

Beyond the preview

Go deeper on Circulating inflammatory mediators and activated immune cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circulating inflammatory mediators and activated immune cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call